Thursday– 20th November 2025 – Conference Day 2 - EST
- Brett Nussbaum - Director of Gross to Net Accounting, Novartis
Negotiations
Discounts
Inflation penalty
What are companies seeing on invoices that have been issued
How should companies prepare
Lessons learned and takeaways
- Shirley Rong - Pricing & Channel Forecasting Lead, UCB
Building optimal organizational structure
Responsibilities and ownership
Communication and workflow outline for success
Round table discussions with peers from other departments to understand challenges and determine where improvements can be made
Take actionable insights back to your organization to share with your teams
- Edward McAdam - Director, Government Pricing, Contracting Operations & Analytics, Indivior
- Darpan Jhaveri - Senior Director - US Revenue and Inventory Accounting,, Insmed Incorporated
- Dominic Fatigati - Finance Director, Market Access, US Oncology,, AstraZeneca
- Matthew Pellegrini - Sr. Director - Revenue Optimization Contracting & Compliance N.A., Teva Pharmaceuticals
- Prakash Chainani - Vice President- Finance, HR & IT, Lifestar Pharma LLC (a Mankind Group Company)
Enjoy short demonstrations from vendors on the latest technology and advancements to enhance your GTN functionality
- Partha Chatterjee - Co-founder, Partner,, Akara Group
Overview of methodologies used
What variables are considered in the forecasting process
How does the team get involved
Pain points and challenges that hinder accuracy
- Robert Lucchesi - Director, FP&A Sales Reporting & Forecasting, Novo Nordisk
Common challenges in pricing adjustments and how to overcome them
Systems used that aid in the process
Procedures that align with regulatory landscape
Audit and compliance perspectives
- Ranish Singhvi - Vice President, Finance, Accord Healthcare
Join your peers for the opportunity to network and engage with thought leaders, while discussing the complexities of the Gross-To-Net environment. This session will address any remaining questions and offer brainstorming opportunities as the industry looks to the future for more efficient and advanced GTN processes.
- Robert Lucchesi - Director, FP&A Sales Reporting & Forecasting, Novo Nordisk